|
Mr. Voris spent nearly three decades at Lilly, serving in a variety of leadership roles, including Executive Vice President of the Lilly subsidiary PCS Health Systems. He also served as the Executive Director of the Infectious Disease Business Unit and throughout his time at Lilly, gained experience in sales and marketing both in the U.S. and abroad. Currently, Mr. Voris serves as CEO of HAPC, Inc., a special purpose acquisition company. Previously, Mr. Voris was the President and CEO during the start-up and development phases of Epocrates, Inc., a software company providing clinical information to healthcare professionals at the point of care. He continues his association with Epocrates as a member of the Board and also serves on the Board of Gentiae, a successful clinical research company. Mr. Voris is a graduate of the Kelley School of Business at Indiana University, where he earned both a bachelor's degree and an M.B.A. | 